86 related articles for article (PubMed ID: 22288841)
1. Microencapsulated Saccharomyces cerevisiae column bioreactor for potential use in renal failure uremia.
Coussa RG; Shah S; Jain P; Martoni C; Bhathena J; Malhotra M; Prakash S
Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):103-12. PubMed ID: 22288841
[TBL] [Abstract][Full Text] [Related]
2. Microencapsulated genetically engineered E. coli DH5 cells for plasma urea and ammonia removal based on: 1. Column bioreactor and 2. Oral administration in uremic rats.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):201-18. PubMed ID: 8773740
[TBL] [Abstract][Full Text] [Related]
3. Oral microencapsulated live Saccharomyces cerevisiae cells for use in renal failure uremia: preparation and in vivo analysis.
Coussa R; Martoni C; Bhathena J; Urbanska AM; Prakash S
J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20798777
[TBL] [Abstract][Full Text] [Related]
4. Removal of uremic waste metabolites from the intestinal tract by encapsulated carbon and oxidized starch.
Sparks RE; Mason NS; Meier PM; Litt MH; Lindan O
Trans Am Soc Artif Intern Organs; 1971; 17():229-38. PubMed ID: 5158097
[No Abstract] [Full Text] [Related]
5. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats.
Prakash S; Chang TM
Nat Med; 1996 Aug; 2(8):883-7. PubMed ID: 8705857
[TBL] [Abstract][Full Text] [Related]
6. Construction and performance of a minibioreactor suitable as experimental bioartificial liver.
Rodriguez JV; Pizarro MD; Scandizzi AL; Guibert EE; Almada LL; Mamprin ME
Artif Organs; 2008 Apr; 32(4):323-8. PubMed ID: 18370948
[TBL] [Abstract][Full Text] [Related]
7. [Pathogenesis of uremia].
Dobbelstein H
Internist (Berl); 1971 Mar; 12(3):76-84. PubMed ID: 4995899
[No Abstract] [Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Improved survival and ammonia metabolism by intraperitoneal transplantation of microencapsulated hepatocytes in totally hepatectomized rats.
Umehara Y; Hakamada K; Seino K; Aoki K; Toyoki Y; Sasaki M
Surgery; 2001 Sep; 130(3):513-20. PubMed ID: 11562677
[TBL] [Abstract][Full Text] [Related]
10. Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound.
Giannattasio P; Minutolo R; Bellizzi V; Di Iorio BR; Scigliano R; Zamboli P; Venditti G; Manganelli R; De Simone W; Aucella F; Stallone C; Spiezia S; Conte G; De Nicola L
Am J Kidney Dis; 2006 Jun; 47(6):1045-54. PubMed ID: 16731300
[TBL] [Abstract][Full Text] [Related]
11. The potential of a microencapsulated urease-zeolite oral sorbent for the removal of urea in uremia.
Cattaneo MV; Chang TM
ASAIO Trans; 1991; 37(2):80-7. PubMed ID: 1649615
[TBL] [Abstract][Full Text] [Related]
12. The effect of chronic uremia on portal and systemic ammonemia in normal and portal-strictured rats.
Imler M; Schlienger JL
J Lab Clin Med; 1979 Dec; 94(6):872-8. PubMed ID: 501211
[TBL] [Abstract][Full Text] [Related]
13. Live E. coli cells to treat uremia.
Wrong O
Nat Med; 1997 Jan; 3(1):3; author reply 3-4. PubMed ID: 8986726
[No Abstract] [Full Text] [Related]
14. Possible uremic detoxification via oral-ingested microcapsules.
Gardner DL; Falb RD; Kim BC; Emmerling DC
Trans Am Soc Artif Intern Organs; 1971; 17():239-45. PubMed ID: 5158099
[No Abstract] [Full Text] [Related]
15. Preparation and in vitro analysis of microencapsulated genetically engineered E. coli DH5 cells for urea and ammonia removal.
Prakash S; Chang TM
Biotechnol Bioeng; 1995 Jun; 46(6):621-6. PubMed ID: 18623357
[TBL] [Abstract][Full Text] [Related]
16. [A technic of preparation of an intestinal loop in the rat for the study ofjejunal dialysis in the treatment of uremia].
Hamburger J; Donovski L; Marche C
Pathol Biol (Paris); 1970 Apr; 18(7):403-6. PubMed ID: 4911092
[No Abstract] [Full Text] [Related]
17. Use of ultrathin shell microcapsules of hepatocytes in bioartificial liver-assist device.
Sun T; Chan ML; Zhou Y; Xu X; Zhang J; Lao X; Wang X; Quek CH; Chen JP; Leong KW; Yu H
Tissue Eng; 2003; 9 Suppl 1():S65-75. PubMed ID: 14511471
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a novel Wave Bioreactor cellbag for aerobic yeast cultivation.
Mikola M; Seto J; Amanullah A
Bioprocess Biosyst Eng; 2007 Jul; 30(4):231-41. PubMed ID: 17340094
[TBL] [Abstract][Full Text] [Related]
19. Problems and solutions for artificial kidney.
Vanholder R
Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583
[TBL] [Abstract][Full Text] [Related]
20. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.
Basile C; Libutti P; Di Turo AL; Casino FG; Vernaglione L; Tundo S; Maselli P; De Nicolò EV; Ceci E; Teutonico A; Lomonte C
Nephrol Dial Transplant; 2011 Apr; 26(4):1296-303. PubMed ID: 20813765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
